424 related articles for article (PubMed ID: 35585716)
1. Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR-103b/877-5p/29c-5p as diagnostic biomarkers for early lung adenocarcinoma.
Wu J; Feng Z; Wang R; Li A; Wang H; He X; Shen Z
Cancer Med; 2022 Dec; 11(23):4411-4421. PubMed ID: 35585716
[TBL] [Abstract][Full Text] [Related]
2. Identification of hsa-miR-619-5p and hsa-miR-4454 in plasma-derived exosomes as a potential biomarker for lung adenocarcinoma.
Feng L; Feng Z; Hu J; Gao J; Li A; He X; Liu L; Shen Z
Front Genet; 2023; 14():1138230. PubMed ID: 37252659
[No Abstract] [Full Text] [Related]
3. Tumor-derived circulating exosomal miR-342-5p and miR-574-5p as promising diagnostic biomarkers for early-stage Lung Adenocarcinoma.
Han Z; Li Y; Zhang J; Guo C; Li Q; Zhang X; Lan Y; Gu W; Xing Z; Liang L; Li M; Mi S
Int J Med Sci; 2020; 17(10):1428-1438. PubMed ID: 32624699
[TBL] [Abstract][Full Text] [Related]
4. Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma.
Xue X; Wang C; Xue Z; Wen J; Han J; Ma X; Zang X; Deng H; Guo R; Asuquo IP; Qin C; Wang H; Gao Q; Liu S; Wang J
Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):281-293. PubMed ID: 32073597
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic tumor-derived exosomal miR-31-5p promotes lung adenocarcinoma metastasis by negatively regulating SATB2-reversed EMT and activating MEK/ERK signaling.
Yu F; Liang M; Huang Y; Wu W; Zheng B; Chen C
J Exp Clin Cancer Res; 2021 Jun; 40(1):179. PubMed ID: 34074322
[TBL] [Abstract][Full Text] [Related]
6. Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression.
Chen HL; Luo YP; Lin MW; Peng XX; Liu ML; Wang YC; Li SJ; Yang DH; Yang ZX
Cancer Med; 2022 Jul; 11(13):2627-2643. PubMed ID: 35347894
[TBL] [Abstract][Full Text] [Related]
7. A combination of four serum miRNAs for screening of lung adenocarcinoma.
Wang J; Zhang C; Peng X; Liu K; Zhao L; Chen X; Yu H; Lai Y
Hum Cell; 2020 Jul; 33(3):830-838. PubMed ID: 32388809
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
[No Abstract] [Full Text] [Related]
9. Identification of exosomal hsa-miR-483-5p as a potential biomarker for hepatocellular carcinoma via microRNA expression profiling of tumor-derived exosomes.
Lin J; Lin W; Bai Y; Liao Y; Lin Q; Chen L; Wu Y
Exp Cell Res; 2022 Aug; 417(2):113232. PubMed ID: 35659970
[TBL] [Abstract][Full Text] [Related]
10. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in
Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q
J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728
[TBL] [Abstract][Full Text] [Related]
11. Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma.
Ren ZP; Hou XB; Tian XD; Guo JT; Zhang LB; Xue ZQ; Deng JQ; Zhang SW; Pan JY; Chu XY
FEBS Open Bio; 2019 Feb; 9(2):315-327. PubMed ID: 30761256
[TBL] [Abstract][Full Text] [Related]
12. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
Sui MH; Zhang WW; Geng DM; Sun DJ
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
[TBL] [Abstract][Full Text] [Related]
13. Exosomal microRNA-26b-5p down-regulates ATF2 to enhance radiosensitivity of lung adenocarcinoma cells.
Han F; Huang D; Huang X; Wang W; Yang S; Chen S
J Cell Mol Med; 2020 Jul; 24(14):7730-7742. PubMed ID: 32476275
[TBL] [Abstract][Full Text] [Related]
14. Serum exosomal miR-7977 as a novel biomarker for lung adenocarcinoma.
Chen L; Cao P; Huang C; Wu Q; Chen S; Chen F
J Cell Biochem; 2020 Jun; 121(5-6):3382-3391. PubMed ID: 31898829
[TBL] [Abstract][Full Text] [Related]
15. Application of miRNA Biomarkers in Predicting Overall Survival Outcomes for Lung Adenocarcinoma.
Li T; Liu H; Dong C; Lyu J
Biomed Res Int; 2022; 2022():5249576. PubMed ID: 36147635
[TBL] [Abstract][Full Text] [Related]
16. Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma.
Gao S; Guo W; Liu T; Liang N; Ma Q; Gao Y; Tan F; Xue Q; He J
Cancer Sci; 2022 Feb; 113(2):648-659. PubMed ID: 34837453
[TBL] [Abstract][Full Text] [Related]
17. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
Tan J; Wang W; Song B; Song Y; Meng Z
Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
[TBL] [Abstract][Full Text] [Related]
18. Identification of Three Differentially Expressed miRNAs as Potential Biomarkers for Lung Adenocarcinoma Prognosis.
Wang W; Liu B; Duan X; Feng X; Wang T; Wang P; Ding M; Zhang Q; Feng F; Wu Y; Yao W; Wang Q; Yang Y
Comb Chem High Throughput Screen; 2020; 23(2):148-156. PubMed ID: 31976830
[TBL] [Abstract][Full Text] [Related]
19. A panel of miRNAs derived from plasma extracellular vesicles as novel diagnostic biomarkers of lung adenocarcinoma.
Yao B; Qu S; Hu R; Gao W; Jin S; Liu M; Zhao Q
FEBS Open Bio; 2019 Dec; 9(12):2149-2158. PubMed ID: 31677346
[TBL] [Abstract][Full Text] [Related]
20. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
